首页> 外文OA文献 >Preclinical Pharmacokinetics and Safety of Sym004: A Synergistic Antibody Mixture Directed against Epidermal Growth Factor Receptor

【2h】

Preclinical Pharmacokinetics and Safety of Sym004: A Synergistic Antibody Mixture Directed against Epidermal Growth Factor Receptor

机译：突出的药代动力学和Sym004的安全性：针对表皮生长因子受体的协同抗体混合物

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Niels Jørgen Østergaard Skartved; Helle Jane Jacobsen; Mikkel Wandahl Pedersen; Pernille Foged Jensen; Jette Wagtberg Sen; Thomas Kjærsgaard Jørgensen; Adam Hey; Michael Kragh;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Preclinical pharmacokinetics and safety of Sym004: a synergistic antibody mixture directed against epidermal growth factor receptor. [J] . Skartved NJ, Jacobsen HJ, Pedersen MW, Clinical cancer research: an official journal of the American Association for Cancer Research . 2011,第18期

机译：Sym004的临床前药代动力学和安全性：针对表皮生长因子受体的协同抗体混合物。
2. Sym004: a novel synergistic anti-epidermal growth factor receptor antibody mixture with superior anticancer efficacy. [J] . Pedersen MW, Jacobsen HJ, Koefoed K, Cancer research: The official organ of the American Association for Cancer Research, Inc . 2010,第2期

机译：Sym004：具有优异抗癌功效的新型协同抗表皮生长因子受体抗体混合物。
3. Population pharmacokinetics and covariate analysis of Sym004, an antibody mixture against the epidermal growth factor receptor, in subjects with metastatic colorectal cancer and other solid tumors [J] . Lene Alifrangis, Rik Schoemaker, Niels J. Skartved, Journal of pharmacokinetics and pharmacodynamics . 2020,第1期

机译：人口药代动力学和对符号的调药分析，对表皮生长因子受体的抗体混合物，在转移结直肠癌和其他实体肿瘤的受试者中
4. Effect of preoperative cancer treatment on epidermal growth factor receptor (EGFR) receptor expression level in ABY-029 guided sarcoma surgery [C] . Xiaochun Xu, Kimberley S Samkoe, Eric R. Henderson Society of Photo-Optical Instrumentation Engineers;Conference on Molecular-Guided Surgery: Molecules, Devices, and Applications . 2020

机译：术前癌症治疗对ABY-029导向肉瘤手术中表皮生长因子受体（EGFR）受体表达水平的影响
5. Cloning and expression of a biosimilar chimeric monoclonal antibody directed against the human epidermal growth factor receptor and its production in CHO cells for treatment of colo-rectal cancer. [D] . Motiwala, Hatim Maqbulhusen. 2012

机译：针对人表皮生长因子受体的生物仿制药嵌合单克隆抗体的克隆和表达及其在CHO细胞中的产生，用于治疗结肠直肠癌。
6. Growth inhibition of human lung adenocarcinoma cells by antibodies against epidermal growth factor receptor and by ganglioside GM3: involvement of receptor-directed protein tyrosine phosphatase(s). [O] . E. Suarez Pestana, U. Greiser, B. Sánchez, 1997

机译：抗表皮生长因子受体的抗体和神经节苷脂GM3对人肺腺癌细胞的生长抑制：受体定向蛋白酪氨酸磷酸酶的参与。
7. Sym004: A Novel Synergistic Anti–Epidermal Growth Factor Receptor Antibody Mixture with Superior Anticancer Efficacy [O] . Mikkel Wandahl Pedersen, Helle Jane Jacobsen, Klaus Koefoed, 2010

机译：SYM004：一种新型协同抗表皮生长因子受体抗体混合物，具有优异的抗癌疗效

Preclinical Pharmacokinetics and Safety of Sym004: A Synergistic Antibody Mixture Directed against Epidermal Growth Factor Receptor

著录项

引文网络

相似文献

相关主题

期刊订阅